Increased frequency of chromosomal abnormalities in female partners of couples undergoing in vitro fertilization or intracytoplasmic sperm injection. 2000

A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
Gasthuisberg University Hospital, Leuven, Belgium.

OBJECTIVE To determine the prevalence of chromosomal abnormalities in female partners of couples undergoing IVF or intracytoplasmic sperm injection (ICSI). METHODS Prospective study. METHODS Leuven University Fertility Center. METHODS Female candidates for IVF or ICSI. METHODS An initial cytogenetic study was performed on peripheral blood lymphocyte cultures using G- and R-banding. In all patients, > or =25 metaphases were examined. If a chromosomal aberration was detected, additional cytogenetic studies were performed for precise identification. METHODS Abnormal female karyotypes in comparison with the general female population. RESULTS Cytogenetic analysis was performed in 263 female partners of couples before entering an IVF or ICSI program. The prevalence of autosomal reciprocal balanced translocations was seven times higher in the study group (1.14%) than in the general population (0.16%). All abnormal karyotypes were found in the IVF group with male factor infertility. CONCLUSIONS Chromosomal abnormalities are more frequent in the female partners of couples seeking fertility treatment. We recommend chromosomal analysis in women before starting IVF or ICSI treatment, even in the presence of male factor infertility.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001530 Belgium A country in Western Europe, bordering the North Sea, between France and the Netherlands. The capital is Brussels.
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
January 1998, Human reproduction (Oxford, England),
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
April 2010, Journal of genetics,
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
December 2016, The Journal of international medical research,
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
June 2004, International journal of andrology,
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
July 2003, Microscopy research and technique,
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
January 2006, Fertility and sterility,
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
September 1995, Lancet (London, England),
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
December 1995, Lancet (London, England),
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
November 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
A Schreurs, and E Legius, and C Meuleman, and J P Fryns, and T M D'Hooghe
September 1999, Human reproduction (Oxford, England),
Copied contents to your clipboard!